Revance Therapeutics Merger Stockholder Litigation
Checked October 14, 2026 against the official notice · Edited by Ferhat Abdullahoglu
If you held Revance Therapeutics, Inc. common stock as of February 6, 2025, and your shares were exchanged for $3.65 per share in the merger with Crown Laboratories, Inc., you may be eligible for a payment. You must submit a Proof of Claim to receive a payment from the $2.4 million settlement fund.
Who qualifies
- Anywhere in the United States.
- Products: Revance Therapeutics, Inc. common stock.
“ALL RECORD HOLDERS AND ALL BENEFICIAL HOLDERS OF REVANCE THERAPEUTICS, INC.”From the court-approved notice
What you can get
These are the amounts the settlement publishes. Shares of a fund depend on how many people file: what pro rata means.
How to file
- 1. Check that the class description above fits you.
- 2. File on the official claim form by March 17, 2027. It usually takes a few minutes.
Key dates
When settlements pay, and what can delay it.
Is this settlement legit?
Yes. It's a court-approved class action settlement in the Court of Chancery of the State of Delaware (case 2025-1415-NAC). The official site is rg2claims.com. You never pay to file a claim. How to check a settlement notice.
Related settlements
ClaimWell summarizes the official notice so it's easier to read. It isn't legal advice; the official settlement site is the authority on who qualifies and what each claim pays.